Cannabinoid Receptor Interacting Protein isoform 1b (CRIP1b) is known to interact with the CB1 receptor. Alternative splicing of the CNRIP1 gene produces CRIP1a and CRIP1b with a difference in the third exon only. Exons 1 and 2 encode for a functional domain in both proteins. CRIP1a is involved in regulating CB1 receptor internalization, but the function of CRIP1b is not very well characterized. Since there are significant identities in functional domains of these proteins, CRIP1b is a potential target for drug discovery. We report here predicted structure of CRIP1b followed by its interaction analysis with CB1 receptor by in-silico methods. A number of complementary computational techniques, including, homology modeling, ab-initio and protein threading, were applied to generate three-dimensional molecular models for CRIP1b. The computed model of CRIP1b was refined, followed by docking with C terminus of CB1 receptor to generate a model for the CRIP1b- CB1 receptor interaction. The structure of CRIP1b obtained by homology modelling using RHO_GDI-2 as template is a sandwich fold structure having beta sheets connected by loops, similar to predicted CRIP1a structure. The best scoring refined model of CRIP1b in complex with the CB1 receptor C terminus peptide showed favourable polar interactions. The overall binding pocket of CRIP1b was found to be overlapping to that of CRIP1a. The Arg82 and Cys126 of CRIP1b are involved in the majority of hydrogen bond interactions with the CB1 receptor and are possible key residues required for interactions between the CB1 receptor and CRIP1b.
In diabetes, hyperglycemia activates MMPs that along with the other pathogenic mediators cause neuronal injury and precipitates neuropathic pain. Thus, MMPs play a crucial role in the development of neuropathic pain among diabetics. However, MMPs are not only responsible for deleterious ECM abnormalities but are also required for beneficial remodeling of ECM under normal physiological conditions. Therefore, highly selective and specific inhibitors must be designed and explored for their clinical potential for treatment/prevention of diabetic neuropathic pain.
We have investigated the structure of the distal C-terminal
domain
of the of the CB1 cannabinoid receptor (CB1R) to study
its interactions with CRIP1a and CRIP1b using computational techniques.
The amino acid sequence from the distal C-terminal domain of CB1R
(G417-L472) was found to be unique, as it does
not share sequence similarity with other protein structures, so the
structure was predicted using ab initio modeling.
The computed model of the distal C-terminal region of CB1R has a helical
region between positions 441 and 455. The CRIP1a and CRIP1b were modeled
using Rho-GDI 2 as a template. The three-dimensional model of the
distal C-terminal domain of the CB1R was docked with both CRIP1a as
well as CRIP1b to study the crucial interactions between CB1R and
CRIP1a/b. The last nine residues of CB1R (S464TDTSAEAL4722) are known to be a CRIP1a/b binding site. The majority
of the key interactions were identified in this region, but notable
interactions were also observed beyond theses nine residues. The multiple
interactions between Thr418 (CB1R) and Asn61 (CRIP1a) as well as Asp430
(CB1R) and Lys76 (CRIP1a) indicate their importance in the CB1R–CRIP1a
interaction. In the case of CRIP1b, multiple hydrogen bond interactions
between Asn437 (CB1R) and Glu77 (CRIP1b) were observed. These interactions
can be critical for CB1R’s interaction with CRIP1a/b, and targeting
them for further experimental studies can advance information about
CRIP1a/b functionality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.